首页> 外文OA文献 >Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

【2h】

Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

机译：鞘内曲妥珠单抗：免疫疗法可改善HER-2 +乳腺癌患者软脑膜转移的预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nu T. Lu; Jeffrey Raizer; Erwin P. Gabor; Natalie M. Liu; James Q. Vu; Dennis J. Slamon; John L. Barstis;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient [J] . Nu T. Lu, Jeffrey Raizer, Erwin P. Gabor, Journal for ImmunoTherapy of Cancer . 2015,第S1期

机译：鞘内曲妥珠单抗：免疫疗法可改善HER-2 +乳腺癌患者软脑膜转移的预后
2. Cyberknife Radiosurgery and Concurrent Intrathecal Chemotherapy for Leptomeningeal Metastases: Case Report of Prolonged Survival of a HER-2+ Breast Cancer Patient Status-Post Craniospinal Irradiation [J] . Gregory Lekovic, Doniel Drazin, Albert C. Mak, Cureus. . 2016,第1期

机译：射波刀放射外科手术和并行鞘内化学疗法治疗肾小脑膜转移瘤：HER-2 +乳腺癌患者长期颅骨脊髓照射后生存期延长的病例报告
3. TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：TBCRC049：II期非随机性研究，以评估Tucatinib和Trastuzumab和Capecitabine的组合的安全性和功效，用于治疗Her2阳性乳腺癌TBCRC049中的百分声膜转移：II期非随机性研究，以评估安全性和疗效 Tucatinib和Trastuzumab和Capecitabine的组合治疗HER2阳性乳腺癌中的百分症转移
4. INTEGRATION OF MICROARRAY AND TEXTUAL DATA IMPROVES THE PROGNOSIS PREDICTION OF BREAST, LUNG AND OVARIAN CANCER PATIENTS [C] . O. GEVAERT, S. VAN VOOREN, B. DE MOOR Pacific Symposium on Biocomputing; 20080104-08; Kohala Coast,HI(US) . 2008

机译：微阵列和文本数据的整合改善了乳腺癌，肺癌和卵巢癌患者的预后预测
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient [O] . Nu T. Lu, Jeffrey Raizer, Erwin P. Gabor, 2015

机译：鞘内曲妥珠单抗：免疫疗法可改善HER-2 +乳腺癌患者软脑膜转移的预后
7. Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer [O] . Francisco José Valdivia García, Natalia Palazón Carrión, Luis de la Cruz-Merino 2020

机译：由于HER2-过度抑制乳腺癌，对患者患者患者患者患者的长期完全反应

Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient

著录项

引文网络

相似文献

相关主题

期刊订阅